The present invention provides parenteral adjuvants comprising detoxified mutants of bacterial ADP-ribosylating toxins, particularly those from pertussis (PT), cholera (CT), and heat-labile E. coli (LT).

 
Web www.patentalert.com

< HCV variants

< Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection

> Macrocyclic peptides active against the hepatitis C virus

> Immunogenic Hepatitis C virus non-structural polypeptides
~ 00269